Lifeway Foods hits record $212M in sales as probiotic demand surges
Lifeway Foods (NASDAQ:LWAY) reported a strong conclusion to its 2025 fiscal year, fueled by consistent volume growth across its core probiotic dairy portfolio.
Every story in this section, newest first — page 253 of 373.
Lifeway Foods (NASDAQ:LWAY) reported a strong conclusion to its 2025 fiscal year, fueled by consistent volume growth across its core probiotic dairy portfolio.
IceCure Medical (NASDAQ:ICCM) announced record financial results for the fourth quarter and full year ended December 31, 2025, marking a transformative period for the Israeli medtech firm.
Academy Sports + Outdoors (NASDAQ:ASO) reported a solid conclusion to fiscal 2025, with full-year net sales climbing 2% to reach a milestone of $6.05 billion.
Telesat (NASDAQ:TSAT) reported a net loss of $90.1 million for the fourth quarter ended December 31, 2025.
Mastercard (NYSE:MA) today signaled a major shift in the global payments landscape by announcing the acquisition of BVNK, a prominent provider of stablecoin and digital asset infrastructure.
Neuronetics (NASDAQ:STIM), the leader in Transcranial Magnetic Stimulation (TMS) therapy for mental health, reported its fourth-quarter and full-year 2025 financial results, reflecting the transformative impact of its late-2024 acquisition of Greenbrook TMS.
Corporación América Airports (NYSE:CAAP), one of the world's largest private airport operators, delivered a strong finish to fiscal 2025, characterized by robust top-line growth and a dramatic expansion in profitability.
CervoMed (NASDAQ:CRVO) announced on Tuesday that it has achieved critical regulatory and clinical alignment for the Phase 3 development of neflamapimod, its oral small-molecule treatment for dementia with Lewy bodies (DLB).
Abeona Therapeutics (NASDAQ:ABEO) on Wednesday reported financial results for the full year ended December 31, 2025, and provided operational updates centered on the commercial launch of its lead gene therapy ZEVASKYN.
X4 Pharmaceuticals (NASDAQ:XFOR) reported its fourth-quarter and full-year 2025 financial results on March 17, 2026, marking a year of transition from a clinical-stage entity to a commercial-revenue-generating firm.
Victory Capital Holdings (NASDAQ:VCTR) increased the pressure on Janus Henderson Group (NYSE:JHG) today, submitting an enhanced acquisition proposal to the company’s Special Committee.
GDS Holdings (NASDAQ:GDS) reported audited financial results for the fourth quarter and full year ended December 31, 2025, demonstrating resilient growth in its hyperscale data center operations.
Steel Dynamics (NASDAQ:STLD) provided a bullish outlook for the first quarter of 2026, signaling a significant acceleration in profitability compared to both the previous quarter and the prior year.
Pfizer (NYSE:PFE) reported a significant clinical milestone in its oncology pipeline today, announcing that the Phase 2 FOURLIGHT-1 study of atirmociclib met its primary endpoint.
Citi Trends (NASDAQ:CTRN) reported a robust recovery for the fourth quarter ended January 31, 2026, marking a pivotal turn for the off-price retailer.
PSQ Holdings (NYSE:PSQH), the operator of the PublicSquare marketplace and its associated payments infrastructure, released its fourth-quarter and full-year 2025 financial results on March 17, 2026.
Value Line (NASDAQ:VALU) reported financial results for its fiscal third quarter ended January 31, 2026, posting a net income of $5.9 million.
BioCardia (NASDAQ:BCDA) announced on Tuesday that the U.S. Food and Drug Administration has accepted its pre-submission package for the Helix Transendocardial Delivery Catheter.
AtaiBeckley (NASDAQ:ATAI) announced on Tuesday that results from a Phase 2a cohort evaluating BPL-003, its proprietary intranasal formulation of 5-MeO-DMT, have been published in the Journal of Psychopharmacology.
Greenwich LifeSciences (NASDAQ:GLSI) released a preliminary update from its ongoing Phase III FLAMINGO-01 clinical trial, which evaluates the efficacy of GP2, an immunotherapy designed to prevent breast cancer recurrences.
Atour Lifestyle Holdings (NASDAQ:ATAT) reported full-year 2025 financial results on Tuesday, illustrating the success of its "high-quality expansion" strategy within China’s upper-midscale hospitality market.
Elbit Systems (NASDAQ:ESLT) reported record-breaking financial results for the full year ended December 31, 2025, illustrating the defense contractor's critical role in a volatile global security landscape.
BingEx (NASDAQ:FLX) on Tuesday reported unaudited financial results for the fourth quarter and full year ended December 31, 2025, showing a year-over-year revenue decline amid ongoing adjustments in the cross-border e-commerce logistics sector.
36Kr Holdings (NASDAQ:KRKR) reported its unaudited financial results for the second half and full year of 2025, marking a significant operational turnaround for the Beijing-based content and business services platform.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy